These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 183644)

  • 41. Equine rhinopneumonitis vaccine: immunogenicity and safety in foals.
    Purdy CW; Porter RC; Ford SJ
    Am J Vet Res; 1978 May; 39(5):745-52. PubMed ID: 215062
    [No Abstract]   [Full Text] [Related]  

  • 42. Occurrence of equine coital exanthema in pastured draft horses and isolation of equine herpesvirus 3 from progenital lesions.
    Seki Y; Seimiya YM; Yaegashi G; Kumagai S; Sentsui H; Nishimori T; Ishihara R
    J Vet Med Sci; 2004 Dec; 66(12):1503-8. PubMed ID: 15644599
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1.
    Foote CE; Raidal SL; Pecenpetelovska G; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2006 May; 111(1-2):97-108. PubMed ID: 16504306
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Isolation of equine herpesvirus 3 (EHV-3) from equine coital exanthema of two stallions and sero-epidemiology of EHV-3 infection in Japan.
    Kirisawa R; Toishi Y; Akamatsu A; Soejima K; Miyashita T; Tsunoda N
    J Vet Med Sci; 2017 Mar; 79(3):636-643. PubMed ID: 28132964
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro cytotoxicity of serum and peripheral blood leukocytes for equine herpesvirus type 1-infected target cells.
    Wilks CR
    Am J Vet Res; 1977 Jan; 38(1):117-21. PubMed ID: 189645
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The pathogenicity of Ab4p, the sequenced strain of equine herpesvirus-1, in specific pathogen-free foals.
    Gibson JS; Slater JD; Field HJ
    Virology; 1992 Jul; 189(1):317-9. PubMed ID: 1318607
    [TBL] [Abstract][Full Text] [Related]  

  • 47. On-site detection of equid alphaherpesvirus 3 in perineal and genital swabs of mares and stallions.
    Vissani MA; Tordoya MS; Tsai YL; Lee PA; Shen YH; Lee FC; Wang HT; Parreño V; Barrandeguy M
    J Virol Methods; 2018 Jul; 257():29-32. PubMed ID: 29627335
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A type-specific serological test to distinguish antibodies to equine herpesviruses 4 and 1.
    Crabb BS; MacPherson CM; Reubel GH; Browning GF; Studdert MJ; Drummer HE
    Arch Virol; 1995; 140(2):245-58. PubMed ID: 7710353
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determination of equid herpesvirus 1-specific, CD8+, cytotoxic T lymphocyte precursor frequencies in ponies.
    O'Neill T; Kydd JH; Allen GP; Wattrang E; Mumford JA; Hannant D
    Vet Immunol Immunopathol; 1999 Sep; 70(1-2):43-54. PubMed ID: 10507286
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Innate immunity during Equid herpesvirus 1 (EHV-1) infection.
    Bridges CG; Edington N
    Clin Exp Immunol; 1986 Jul; 65(1):172-81. PubMed ID: 2431815
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Equine interferons following exposure to equid herpesvirus-1 or -4.
    Edington N; Bridges CG; Griffiths L
    J Interferon Res; 1989 Aug; 9(4):389-92. PubMed ID: 2474039
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nasal shedding of equine herpesvirus-1 from horses in an outbreak of equine herpes myeloencephalopathy in Western Canada.
    Burgess BA; Tokateloff N; Manning S; Lohmann K; Lunn DP; Hussey SB; Morley PS
    J Vet Intern Med; 2012; 26(2):384-92. PubMed ID: 22332764
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses.
    Matsumura T; Kondo T; Sugita S; Damiani AM; O'Callaghan DJ; Imagawa H
    Virology; 1998 Mar; 242(1):68-79. PubMed ID: 9501037
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell-mediated immunity evaluation in foals infected with virulent equine herpesvirus-1 by multi-parameter flow cytometry.
    Platt R; Sponseller BA; Chiang YW; Roth JA
    Vet Immunol Immunopathol; 2010 Jun; 135(3-4):275-81. PubMed ID: 20116862
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuropathogenicity for suckling mice of equine herpesvirus 1 from the Lipizzan outbreak 1983 and of selected other EHV 1 strains.
    Nowotny N; Burtscher H; Bürki F
    Zentralbl Veterinarmed B; 1987 Aug; 34(6):441-8. PubMed ID: 2830747
    [No Abstract]   [Full Text] [Related]  

  • 56. EHV-1 and EHV-4 infection in vaccinated mares and their foals.
    Foote CE; Love DN; Gilkerson JR; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2006 May; 111(1-2):41-6. PubMed ID: 16513181
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Natural killer cells in normal horses and specific-pathogen-free foals infected with equine herpesvirus.
    Chong YC; Duffus WP; Hannant D
    Vet Immunol Immunopathol; 1992 Jun; 33(1-2):103-13. PubMed ID: 1321530
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathogenesis of equine herpesvirus-1 in specific pathogen-free foals: primary and secondary infections and reactivation.
    Gibson JS; Slater JD; Awan AR; Field HJ
    Arch Virol; 1992; 123(3-4):351-66. PubMed ID: 1314051
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of equine herpesvirus-specific effector and memory cytotoxic immunity in the equine upper respiratory tract.
    Breathnach CC; Yeargan MR; Timoney JF; Allen GP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):117-25. PubMed ID: 16472871
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serological responses and clinical outcome after vaccination of mares and foals with equine herpesvirus type 1 and 4 (EHV-1 and EHV-4) vaccines.
    Bresgen C; Lämmer M; Wagner B; Osterrieder N; Damiani AM
    Vet Microbiol; 2012 Nov; 160(1-2):9-16. PubMed ID: 22633483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.